Laura Hurd

1.5k total citations
4 papers, 151 citations indexed

About

Laura Hurd is a scholar working on Cancer Research, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura Hurd has authored 4 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura Hurd's work include Neuroblastoma Research and Treatments (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Laura Hurd is often cited by papers focused on Neuroblastoma Research and Treatments (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Laura Hurd collaborates with scholars based in United States and Australia. Laura Hurd's co-authors include Jun S. Wei, Young Song, Jack F. Shern, Hongling Liao, Javed Khan, Adam Cheuk, Samuel Q. Li, Li Chen, Daniel Catchpoole and Douglas S. Hawkins and has published in prestigious journals such as PLoS ONE, PLoS Genetics and Cancer Investigation.

In The Last Decade

Laura Hurd

4 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Hurd United States	4	96	60	44	43	24	4	151
Krystal Straessler United States	3	70 0.7×	71 1.2×	44 1.0×	43 1.0×	7 0.3×	5	136
Abigail Ward United States	5	74 0.8×	80 1.3×	81 1.8×	56 1.3×	23 1.0×	7	152
Sophie Shifman United States	3	69 0.7×	84 1.4×	47 1.1×	66 1.5×	14 0.6×	5	174
Yeonhwa Jung South Korea	6	140 1.5×	92 1.5×	68 1.5×	93 2.2×	7 0.3×	6	238
Colette Gaba United States	8	91 0.9×	76 1.3×	36 0.8×	46 1.1×	10 0.4×	11	202
Mohammed Bangash Saudi Arabia	7	101 1.1×	37 0.6×	49 1.1×	33 0.8×	21 0.9×	16	214
Elsie F. Wu United States	6	111 1.2×	56 0.9×	26 0.6×	61 1.4×	18 0.8×	7	221
Paul S. Meltzer United States	3	71 0.7×	83 1.4×	31 0.7×	38 0.9×	6 0.3×	7	158
Jinyeong Lim South Korea	7	76 0.8×	42 0.7×	46 1.0×	37 0.9×	5 0.2×	18	157
Vinay Gudena United States	6	53 0.6×	40 0.7×	31 0.7×	102 2.4×	15 0.6×	18	181

Countries citing papers authored by Laura Hurd

Since Specialization

Citations

This map shows the geographic impact of Laura Hurd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hurd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hurd more than expected).

Fields of papers citing papers by Laura Hurd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hurd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hurd. The network helps show where Laura Hurd may publish in the future.

Co-authorship network of co-authors of Laura Hurd

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hurd. A scholar is included among the top collaborators of Laura Hurd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hurd. Laura Hurd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Chen, Li, Jack F. Shern, Jun S. Wei, et al.. (2015). Clonality and Evolutionary History of Rhabdomyosarcoma. PLoS Genetics. 11(3). e1005075–e1005075. 47 indexed citations

2.

Li, Samuel Q., Adam Cheuk, Jack F. Shern, et al.. (2013). Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534). PLoS ONE. 8(10). e76551–e76551. 74 indexed citations

3.

Wei, Jun S., Peter A. Johansson, Li Chen, et al.. (2013). Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma. PLoS ONE. 8(10). e77731–e77731. 21 indexed citations

4.

Stauffer, Jimmy K., Rimas J. Orentas, Tahira Khan, et al.. (2012). High-Throughput Molecular and Histopathologic Profiling of Tumor Tissue in a Novel Transplantable Model of Murine Neuroblastoma: New Tools for Pediatric Drug Discovery. Cancer Investigation. 30(5). 343–363. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact